Person:
Portero Fuentes, Miriam

Profile Picture
First Name
Miriam
Last Name
Portero Fuentes
URI
https://hdl.handle.net/20.500.14352/81577
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Department
Area
Identifiers
UCM identifierORCIDScopus Author IDDialnet ID

Filters

2023 - 20242
Reset filters

Settings

Subject: 636.09 ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Efficacy of Medical Ozone as an Adjuvant Treatment in Dogs with Intervertebral Disc Protusions: A Retrospective Study
    (Animals, 2023) Portero Fuentes, Miriam; Villalonga Rodríguez, Luis; Hernández, Mercedes; Pérez Díaz, Carmen
    Ozone-therapy is used in humans as a coadjutant treatment in intervertebral disc diseases due to its analgesic, anti-inflammatory and antioxidant effects. References in dogs are scarce and limited to clinical cases (intradiscal/paravertebral infiltrations). The aim of this study was to assess the use of medical ozone (MO) as an adjunctive treatment in dogs with intervertebral disc protrusions (Hansen Type II/Chronic). A retrospective study was conducted in dogs diagnosed with intervertebral disc protrusions by MRI/CT in which MO was used as an adjuvant therapy to conventional medical treatment. Neurological examination and quality of life (QL) at the beginning and end of study were recorded, as well as posology and possible side effects. A total of 21 patients of different breeds and sex with a mean age of 12 years were included in this study. Results showed pain relief (7 ± 3 days) and improvement of neurologic signs (11 ± 9 days) with a consequent increasement in QL (13 ± 9 days). Thirteen out of the twenty-one patients (62%) showed a complete remission of the clinical signs. No serious adverse effects were observed. Medical ozone could be a potential complementary therapy to medical treatment in dogs with intervertebral disc protrusions. Prospective studies are necessary.
  • Thumbnail Image
    Item
    Active surveillance of antimicrobial resistance in companion animals: A pilot study in a Spanish Veterinary Teaching Hospital
    (Comparative Immunology, Microbiology and Infectious Diseases, 2024) Scarpellini, Raffaele; Leal Vélez de Mendizábal, Laura; Quevedo Caraballo, Sergio; Blanco Cancelo, José Luis; García Sánchez, Marta Eulalia; Pérez Sancho, Marta; Portero Fuentes, Miriam; Penelo Hidalgo, Silvia; Esposito, Erika; Mondo, Elisabetta; Piva, Silvia
    The role of small animal veterinary hospitals in the onset and dissemination of antimicrobial-resistant organisms (AMROs) is still not clear, and the implementation of an internal surveillance systems is a cost-effective tool to better understand their impact. The aim of this study was to describe a pilot program of active surveillance in a Spanish Veterinary Teaching Hospital, developed to estimate the detection frequency of AMROs in the commensal flora of patients and in the environment. Surveillance was focused on Methicillin-resistant Staphylococci (MRS), third generation cephalosporins resistant gram-negative bacteria (3GCR-GNB), and carbapenems-resistant gram-negative bacteria (CR-GNB). Oral and perirectal swabs were collected in the same dogs and cats hospitalized > 48 h, at their admission and before their discharge. Out of 50 patients sampled, 24% (12/50) were carriers at admission of at least one of the three investigated AMROs. Twenty-eight percent of patients (14/50) acquired at least one AMRO during the hospital stay. MRS detection frequency at admission was 12% (6/50), while acquisition was 6% (3/50). 3GCR-GNB detection frequency was 14% at admission (7/50) and acquisition 22% (11/50), while CR-GNB detection frequency was 2% at admission (1/50) and acquisition 2% (1/50). Environmental surveillance (98 samples) showed a total detection frequency of 22.4% for MRS (22/98), 2% for 3GCR-GNB and CR-GNB (2/98). Clinical staff’ shoe soles showed high detection frequency for MRS (50%). 3GCR Escherichia coli was the most isolated species in patients (n = 17). The results show how active surveillance can be used as a tool to assess the impact of AMROs in veterinary hospitals to subsequently build up tailored control plans based on specific issues.